MARKET

SXTPW

SXTPW

60 Degrees Pharm
NASDAQ
0.0324
+0.0071
+28.06%
Closed 14:45 09/25 EDT
OPEN
0.0270
PREV CLOSE
0.0253
HIGH
0.0379
LOW
0.0270
VOLUME
5.13K
TURNOVER
--
52 WEEK HIGH
0.1499
52 WEEK LOW
0.0226
MARKET CAP
--
P/E (TTM)
-0.0051
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SXTP last week (0914-0918)?
Weekly Report · 5d ago
60 Degrees Advances Babesiosis Treatment With FDA Submission
TipRanks · 09/14 20:32
60 Degrees Pharmaceuticals Says It Submitted Statement Of Interest To FDA For Commissioner's National Priority Voucher For ARAKODA In Babesiosis; DSMB Interim Analysis Of Phase 2 Trial Scheduled October 1, Targets sNDA Submission In March-April 2027
Benzinga · 09/14 20:11
Weekly Report: what happened at SXTP last week (0907-0911)?
Weekly Report · 09/14 10:14
60 Degrees Pharmaceuticals Updates Strategy for Tick-Borne Diseases
TipRanks · 09/08 21:07
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 09/08 21:06
Weekly Report: what happened at SXTP last week (0831-0904)?
Weekly Report · 09/07 10:08
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference
Barchart · 09/03 07:04
More
About SXTPW
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.

Webull offers 60 Degrees Pharmaceuticals Inc stock information, including NASDAQ: SXTPW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SXTPW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SXTPW stock methods without spending real money on the virtual paper trading platform.